Logo

CeGaT Diagnostic Panels

Nov 16, 2016

CeGaT has launched a diagnostic panel for hereditary childhood liver diseases, and updated its diagnostic panel for epilepsy, metabolic, and brain development disorders.The new diagnostic panel for childhood liver disease was designed in collaboration with Ekkehard Sturm, assistant medical of gastroenterology at the University Children's Hospital, Tübingen. The panel is composed of eight gene sets with 118 genes in total, and offers the rapid and simultaneous analysis of all disease-associated genes known to be causative for hereditary childhood liver diseases. The updated panel for epilepsy, metabolic, and brain development disorders sub-divides  639 relevant genes into 28 gene-subsets according to their clinical importance for the single areas of disease. The latest update includes 265 new genes.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.